Search

everythinglearnresearchcommunity

for

Search:↓

Skin reactions from cancer treatments might predict how well the treatments work.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

You might not need to stop cancer treatment if you get a rare skin reaction from EGFR inhibitors, as skin treatments can help manage it.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

The new gel combining calcipotriene and betamethasone is effective and safe for treating scalp psoriasis.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Common acne treatments can cause various side effects, like skin irritation and more serious issues, but combination therapies are often more effective and better tolerated.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

Vitamin A might be a safe extra treatment for dogs with sebaceous adenitis, but more research is needed to prove its effectiveness.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

The document concludes that low-dose acne treatment is most suitable for moderate acne, with high patient satisfaction and low relapse rates.

Topoisomerase inhibitors can cause hair loss, skin rash, hand-foot syndrome, and nail changes.

Topical minoxidil and dietary supplements improved hair regrowth in children with hair loss from chemotherapy.

EGFR deficiency causes significant changes in skin cells and hair follicles.

Finasteride can cause rare but serious skin rashes.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

The convention highlighted the importance of comprehensive patient care and early diagnosis in dermatology.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Some patients treated with peginterferon and ribavirin for chronic hepatitis C had mild to moderate skin reactions, but treatment did not need to be stopped.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

About 22% of cancer patients had skin-related side effects from chemotherapy, but these were usually not severe enough to halt treatment.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.